Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

story of the week

Published in Gastroenterology

Journal Scan / Research · March 31, 2015

Mongersen More Effective Than Placebo for Crohn's Disease

The New England Journal of Medicine

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Disclosure statements are available on the authors' profiles:

Stephen Hanauer MD, MACG

The New England Journal of Medicine

Mongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn's Disease

N. Engl. J. Med 2015 Mar 19;372(12)1104-1113, G Monteleone, MF Neurath, S Ardizzone, A Di Sabatino, MC Fantini, F Castiglione, ML Scribano, A Armuzzi, F Caprioli, GC Sturniolo, F Rogai, M Vecchi, R Atreya, F Bossa, S Onali, M Fichera, GR Corazza, L Biancone, V Savarino, R Pica, A Orlando, F Pallone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Mongersen More Effective Than Placebo for Crohn's Disease

Additional Info

Mongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn's Disease

Further Reading

Providing an Inclusive Environment for LGBTQIA+ Patients in Healthcare

Association of Non-Heavy Alcohol Use With Liver Fibrosis and Nonalcoholic Steatohepatitis

PET Myocardial Perfusion Imaging Findings Predictive of Post–Liver Transplantation Major Adverse Cardiac Events

Association of Antibiotics, Hormonal Therapy, Oral Contraceptives, and Long-Term NSAIDs With the Risk of IBD

Prevalence and Predictors of Barrett's Esophagus After a Negative Result on Initial Endoscopy

Incidence, Management, and Outcomes of Very Early–Onset IBD and Infantile-Onset IBD

Nailing Your Personal Statement

Endoluminal Radiofrequency Ablation in Patients With Malignant Biliary Obstruction

Predicting Residual Neoplasia After a Noncurative Gastric ESD: Validation and Modification of the eCura System in the Western Setting

Clinical Impact of Pancreatic Steatosis Measured by Computed Tomography on the Risk of Post-ERCP Pancreatitis

Patency Capsule Status as a Novel Independent Predictor for Long-Term Outcomes in Patients With Quiescent Crohn's Disease

Recently Updated